Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of a product consisting of four bacteriophages infecting Salmonella enterica ser. Gallinarum B/00111, intended to be used as a zootechnical additive (functional group: other zootechnical additives) for all avian species. The additive (tradename Bafasal (R)) is not currently authorised in the European Union. Bafasal (R) is intended to be used in water for drinking and liquid complementary feed to guarantee a minimum daily dose of 2 x 10(6) PFU/bird, to reduce the Salmonella spp. contamination of poultry carcasses and load in the environment, and to improve the zootechnical performance of the treated animals. In a previous opinion, the FEEDAP Panel could not conclude on the additive's potential to be irritant or a dermal sensitiser, or on its efficacy for any avian species due to insufficient data. The applicant provided supplementary information to address these data gaps. The new data showed that Bafasal (R) is not a skin or eye irritant. No conclusions could be drawn on its skin sensitisation potential. The Panel was not in the position to conclude on the efficacy of Bafasal (R) to improve the zootechnical performance of the target species based on the available data. The additive showed the potential to decrease the counts of two strains of Salmonella Enteritidis in boots swabs and caecal digesta of chickens for fattening. No conclusions could be drawn on the capacity of Bafasal (R) to reduce the contamination of other Salmonella enterica strains, serovars or other species of Salmonella. The potential of Bafasal (R) to reduce the Salmonella spp. contamination poultry carcasses and/or the environment is limited. The FEEDAP Panel recommended a post-market monitoring plan to address the potential selection and spread of resistant variants of Salmonella to Bafasal (R).

Safety and efficacy of a feed additive consisting of the bacteriophages PCM F/00069, PCM F/00070, PCM F/00071 and PCM F/00097 (Bafasal®) for all avian species (Proteon Pharmaceuticals S.A.) / V. Bampidis, G. Azimonti, M.D.L. Bastos, H. Christensen, B. Dusemund, M. Durjava, M. Kouba, M. López‐alonso, S. López Puente, F. Marcon, B. Mayo, A. Pechová, M. Petkova, F. Ramos, Y. Sanz, R.E. Villa, R. Woutersen, L. Herman, M. Anguita, M. Innocenti, E. Pettenati, R. Brozzi. - In: EFSA JOURNAL. - ISSN 1831-4732. - 21:3(2023 Mar 02), pp. e07861.1-e07861.11. [10.2903/j.efsa.2023.7861]

Safety and efficacy of a feed additive consisting of the bacteriophages PCM F/00069, PCM F/00070, PCM F/00071 and PCM F/00097 (Bafasal®) for all avian species (Proteon Pharmaceuticals S.A.)

R.E. Villa;
2023

Abstract

Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of a product consisting of four bacteriophages infecting Salmonella enterica ser. Gallinarum B/00111, intended to be used as a zootechnical additive (functional group: other zootechnical additives) for all avian species. The additive (tradename Bafasal (R)) is not currently authorised in the European Union. Bafasal (R) is intended to be used in water for drinking and liquid complementary feed to guarantee a minimum daily dose of 2 x 10(6) PFU/bird, to reduce the Salmonella spp. contamination of poultry carcasses and load in the environment, and to improve the zootechnical performance of the treated animals. In a previous opinion, the FEEDAP Panel could not conclude on the additive's potential to be irritant or a dermal sensitiser, or on its efficacy for any avian species due to insufficient data. The applicant provided supplementary information to address these data gaps. The new data showed that Bafasal (R) is not a skin or eye irritant. No conclusions could be drawn on its skin sensitisation potential. The Panel was not in the position to conclude on the efficacy of Bafasal (R) to improve the zootechnical performance of the target species based on the available data. The additive showed the potential to decrease the counts of two strains of Salmonella Enteritidis in boots swabs and caecal digesta of chickens for fattening. No conclusions could be drawn on the capacity of Bafasal (R) to reduce the contamination of other Salmonella enterica strains, serovars or other species of Salmonella. The potential of Bafasal (R) to reduce the Salmonella spp. contamination poultry carcasses and/or the environment is limited. The FEEDAP Panel recommended a post-market monitoring plan to address the potential selection and spread of resistant variants of Salmonella to Bafasal (R).
Bafasal®; all avian species; bacteriophages; efficacy; other zootechnical additives; safety; zootechnical additives
Settore VET/07 - Farmacologia e Tossicologia Veterinaria
2-mar-2023
Article (author)
File in questo prodotto:
File Dimensione Formato  
EFSA Journal - 2023 - (1).pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 918.72 kB
Formato Adobe PDF
918.72 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1045591
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 6
  • OpenAlex ND
social impact